Global Pharmatech, Inc.
GBLP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $61,795 | $94,851 | $56,570 | $71,851 |
| - Cash | $30 | $21 | $33 | $0 |
| + Debt | $80 | $0 | $50 | $0 |
| Enterprise Value | $61,845 | $94,830 | $56,587 | $71,851 |
| Revenue | $311 | $66 | $59 | $0 |
| % Growth | 368.4% | 13.3% | – | – |
| Gross Profit | $35 | $44 | $29 | $0 |
| % Margin | 11.1% | 66% | 50.2% | – |
| EBITDA | -$60 | $30 | $208 | -$113 |
| % Margin | -19.3% | 44.8% | 354.3% | – |
| Net Income | -$68 | -$138 | -$21 | -$113 |
| % Margin | -21.8% | -208.7% | -35.9% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 50% | -300% | 75% | – |
| Operating Cash Flow | $15 | -$199 | $391 | -$63 |
| Capital Expenditures | -$15 | $199 | -$229 | $0 |
| Free Cash Flow | $0 | $0 | $163 | -$63 |